news
Mankind Pharma logo is seen in this illustration taken, May 9, 2023. REUTERS/Dado Ruvic/Illustration

 

Shardul Amarchand Mangaldas & Co. has advised Indian pharmaceutical company Mankind Pharma on its 43.26-billion-rupees ($527 million) IPO on the Bombay Stock Exchange and National Stock Exchange, with Cyril Amarchand Mangaldas and Sidley Austin acting for the bookrunning lead managers.

Of the selling shareholders, AZB & Partners advised Cairnhill CIEPF and Cairnhill CGPE, while SAM represented Beige Limited and Link Investment Trust.

The IPO ranks as India’s biggest so far in 2023, and is also the largest among Indian pharma companies to go public since Gland Pharma in 2020, Reuters reported. Mankind Pharma makes at-home pregnancy testing kit Prega News, which has an 80 percent market share in the country, as well as Manforce condoms.

The SAM team advising the issuer was led by Prashant Gupta, national head of the firm’s capital markets practice, who was supported by partner Abhiroop Amitava Datta. Gupta also led the SAM team acting for Beige Limited and Link Investment Trust, assisted by partner Abhinav Maker.

The bookrunning lead managers were Kotak Mahindra Capital, Axis Capital, IIFL Securities, Jefferies India, and JP Morgan India. The Sidley team advising them was led by partner Manoj Bhargava.

Meanwhile, the AZB team was led by partners Darshika Kothari, Varoon Chandra, Agnik Bhattacharyya and Prerak Ved.

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

Deals

CC, Paul Hastings lead on CR Beverages’ HK IPO

by Charlie Wu 吴卓言 |

Clifford Chance and Jingtian & Gongcheng are advising China Resources Beverages, the beverage division of the state-owned China Resources Enterprise, on its upcoming Hong Kong IPO, which is expected to raise up to $1 billion. Paul Hastings and Zhong Lun Law Firm are acting for the joint sponsors.

Deals

CC, Davis Polk act on ChaPanda’s $330 mln Hong Kong IPO

by Charlie Wu 吴卓言 |

Davis Polk & Wardwell and Jingtian & Gongcheng have advised Sichuan Baicha Baidao, a Chinese low-priced tea chain also known as ChaPanda, on its $330 million IPO on the Hong Kong Stock Exchange, with Clifford Chance and King & Wood Mallesons acting for the sponsor CICC and underwriters.

Deals

Skadden, AMT, MHM, Davis Polk advise on Trial Holding’s $258 mln Japan IPO

by Nimitt Dixit |

Skadden, Arps, Slate, Meagher & Flom and Anderson Mori & Tomotsune have advised Japanese discount-store chain operator Trial Holdings on its $258 million initial public offering on the Tokyo Stock Exchange (TSE), the largest IPO of the year so far.